Engine Capital Management, LP - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Engine Capital Management, LP ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2020$319,000
-96.6%
70,212
-93.6%
0.21%
-95.7%
Q1 2020$9,300,000
-54.1%
1,104,5460.0%4.84%
-38.7%
Q4 2019$20,246,000
+65.4%
1,104,5460.0%7.90%
+38.0%
Q3 2019$12,238,000
+8.9%
1,104,5460.0%5.72%
+6.4%
Q2 2019$11,233,000
+80.1%
1,104,546
+3.8%
5.38%
+31.7%
Q1 2019$6,238,000
+0.7%
1,064,546
+22.0%
4.08%
+12.2%
Q4 2018$6,195,000
+84.0%
872,494
+84.3%
3.64%
+14.9%
Q3 2018$3,366,000
+71.4%
473,484
+21.0%
3.17%
+135.6%
Q2 2018$1,964,000
+160.8%
391,307
+472.3%
1.34%
+209.7%
Q1 2018$753,00068,3700.43%
Other shareholders
RECRO PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders